AstraZeneca beats forecasts in Q3, reaffirms full-year guidance By Investing.com - Stock Watch Index

AstraZeneca beats forecasts in Q3, reaffirms full-year guidance By Investing.com

November 6, 2025

AstraZeneca beats forecasts in Q3, reaffirms full-year guidance

Search

RECENT PRESS RELEASES

PyTorch Co-Founder is Leaving Meta

SWI Editorial Staff2025-11-06T13:24:28-08:00November 6, 2025|

Meta brings its short-form video feed of AI slop to Europe

SWI Editorial Staff2025-11-06T13:23:58-08:00November 6, 2025|

Meta reportedly projected 10% of 2024 sales came from scam, fraud ads

SWI Editorial Staff2025-11-06T13:23:37-08:00November 6, 2025|

Meta Expands ‘Vibes’ AI Video Feed to Europe, Embracing the ‘AI Slop’ Its Rivals Shun

SWI Editorial Staff2025-11-06T13:23:18-08:00November 6, 2025|

Meta shares first timeline details for WhatsApp username support

SWI Editorial Staff2025-11-06T13:22:48-08:00November 6, 2025|

Is This the Right Time to Bet on Clean Energy ETFs?

SWI Editorial Staff2025-11-06T12:26:20-08:00November 6, 2025|

Related Post